Aliskiren and diabetic nephropathy

Download this term paper in word format (.doc)

Note: Essay below may appear distorted but all corresponding word document files will contain proper formatting

Excerpt from Term Paper:

6) What questions are still unanswered?

First, the pharmacokinetic and pharmacodynamic properties of oral aliskiren is yet o be discovered. Second, long term studies conducted for at least 2 years should be conducted to further investigate if the beneficial effects of aliskiren on the kidney is maintained.

7) Does the author incorporate their findings in their entirety or in a selective fashion?

The authors were able to discuss the findings as one cohesive study. The results were related to each other, and were cohesive with the problem being investigated.

8)What the study accomplished & what significance the results have on a broad scale?

The study had proven that aliskiren may have beneficial renoprotective effects to patients with diabetic nephropathy and hypertension. The findings are relevant in helping these patients prolong the development of end-stage renal disease.

9) What is your interpretation of the results and how do they differ from the author?

Based on the literature provided and the results of the study, I understood that aliskiren is beneficial to patients who are suffering from diabetic nephropathy. It cannot be ignored that aliskiren can potentially decrease hypertension, despite its lack of significant effect on blood pressure in the study[continue]

Cite this term paper

"Aliskiren And Diabetic Nephropathy" (2008, June 11) Retrieved August 3, 2015, from http://www.paperdue.com/essay/aliskiren-and-diabetic-nephropathy-29390

"Aliskiren And Diabetic Nephropathy" 11 June 2008. Web.3 August. 2015. <http://www.paperdue.com/essay/aliskiren-and-diabetic-nephropathy-29390>

"Aliskiren And Diabetic Nephropathy", 11 June 2008, Accessed.3 August. 2015, http://www.paperdue.com/essay/aliskiren-and-diabetic-nephropathy-29390

Leave a Comment

Register now or post as guest, members login to their existing accounts to post comment.

Copyright 2015 . All Rights Reserved